Jump Financial’s Cellectis CLLS Stock Holding History

Jump Financial’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-14,697	Closed	-$398K	–	983
2020 Q4	$398K	Buy	+14,697	New	+$330K	0.07%	471

Other funds holding CLLS

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bpifrance Maisons Alfort, Cedex, France $1.65B AUM 19.85% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CIA

Capital Impact Advisors Boston, Massachusetts $247M AUM 31.15% 1-Year Est. Return

Jump Financial's CLLS Position: Q1 2021 in Review

Jump Financial sold out of Cellectis (CLLS) in Q1 2021, closing a stake of 14,697 shares — an estimated $398K sold.

Jump Financial first reported a position in CLLS in Q4 2020 and held it in 1 quarter. The position peaked at $398K in Q4 2020. 81 funds tracked by Wall St. Rank hold CLLS as of Q1 2021.

Jump Financial reported no remaining Cellectis position as of Q1 2021 after selling out during the quarter.
Jump Financial sold 14,697 Cellectis shares in Q1 2021, an estimated $398K.
Jump Financial first reported a position in Cellectis in Q4 2020 and held it in 1 quarter.
Jump Financial's Cellectis position peaked at $398K in Q4 2020.
81 funds tracked by Wall St. Rank held Cellectis as of Q1 2021.

Based on Jump Financial's 13F filing for Q1 2021, filed 17 May 2021.